0001127602-20-014098.txt : 20200417
0001127602-20-014098.hdr.sgml : 20200417
20200417192827
ACCESSION NUMBER: 0001127602-20-014098
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200415
FILED AS OF DATE: 20200417
DATE AS OF CHANGE: 20200417
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Machiels Alec
CENTRAL INDEX KEY: 0001496687
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38276
FILM NUMBER: 20800969
MAIL ADDRESS:
STREET 1: 505 PARK AVENUE
STREET 2: 21ST FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001492422
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271537290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-977-5700
MAIL ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-04-15
0001492422
Apellis Pharmaceuticals, Inc.
APLS
0001496687
Machiels Alec
C/O APELLIS PHARMACEUTICALS, INC.
100 FIFTH AVENUE, 3RD FLOOR
WALTHAM
MA
02451
1
Common Stock
2020-04-15
4
M
0
2500
2.67
A
672044
D
Common Stock
2020-04-15
4
S
0
2500
30.00
D
669544
D
Common Stock
1950
I
See Footnote
Stock Option (Right to Buy)
2.67
2020-04-15
4
M
0
2500
0
D
2023-12-04
Common Stock
2500
177529
D
This is a scheduled exercise from 10B5-1 trading plan.
Owned by spouse.
This option was granted on May 12, 2010 and fully vested.
/s/ David Watson, attorney-in-fact for Alec Machiels
2020-04-16